Related Experiment Videos
Interventions for treating trichomoniasis in women
1Department of Gynecology and Obstetrics, Emory University School of Medicine, 69 Butler Street, S.E., Atlanta, Georgia, USA, 30303. fatuforna@hotmail.com
The Cochrane Database of Systematic Reviews
|July 25, 2000
Summary
Single-dose nitroimidazoles effectively treat trichomoniasis in women. Partner treatment is crucial for preventing reinfections and reducing the prevalence of this common sexually transmitted infection.
Area of Science:
- Infectious Diseases
- Public Health
- Women's Health
Background:
- Trichomoniasis, a common sexually transmitted infection, affects approximately 120 million women globally each year.
- The infection is linked to an increased risk of HIV transmission.
Purpose of the Study:
- To evaluate the efficacy of different treatment strategies for trichomoniasis in women.
- To assess the impact of treatment on short-term cure and long-term reinfection rates.
Main Methods:
- Systematic review of 53 randomized and quasi-randomized controlled trials.
- Searches conducted across major databases (Cochrane, MEDLINE, EMBASE) and other sources.
- Independent data extraction and quality assessment by two reviewers.
Main Results:
- Nitroimidazole drugs demonstrated effectiveness for short-term parasitological cure.
- Treatment of male partners was found to be effective in reducing long-term reinfection rates.
Conclusions:
- A single oral dose of nitroimidazoles can achieve parasitological cure.
- Developing effective partner treatment strategies is essential to prevent reinfections and lower trichomoniasis prevalence.